Aktuelle Rheumatologie,
Journal Year:
2024,
Volume and Issue:
49(05), P. 291 - 300
Published: Aug. 9, 2024
Zusammenfassung
Aufgrund
der
erhöhten
Lebenserwartung
und
anhand
epidemiologischer
Daten
zeigt
sich
eine
Zunahme
rheumatische
Erkrankungen
älterer
Menschen.
Diese
Population
ist
durch
ein
erhöhtes
Risiko
für
kardiovaskuläre,
infektiöse,
neoplastische
iatrogene
Komplikationen
betroffen.
Multimorbidität
in
Verbindung
mit
Polypharmazie
progredienten
funktionellen
Defiziten
haben
erheblichen
Einfluss
auf
den
klinischen
Verlauf
die
Therapieentscheidungen
bei
Altersvarianten
rheumatischer
Erkrankungen.
Der
Altersprozess
des
Immunsystems
geprägt
von
Immunseneszenz
„Inflammaging“
Folge
eines
Risikos
Infektionen
Tumorerkrankungen,
verringerten
regenerativen
Potentials
einer
verstärkten
unspezifischen
Entzündungskonstellation.
Neben
wenigen
alterstypischen
rheumatischen
wie
Polymyalgia
rheumatica
gibt
es
Altersformen
Erkrankungen,
hinsichtlich
Symptomatik,
Pathophysiologie,
Labordiagnostik
Prognose
Besonderheiten
aufweisen.
Atypische
Krankheitsverläufe
Mischbilder
degenerativen
oder
anderen
entzündlichen
sind
nicht
ungewöhnlich.
In
Übersichtsarbeit
werden
speziellen
verschiedener
vorgestellt.
Ältere
Patienten
derzeitige
Studienlage
adäquat
erfasst.
Ein
wesentlicher
Schwerpunkt
künftiger
klinisch-rheumatologischer
Forschung
sollte
stärkere
Einbeziehung
dieser
sein,
um
angepasste
integrative
Therapiekonzepte
Morbidität
Mortalität
zu
reduzieren.
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(38)
Published: Sept. 11, 2024
Chaperone-mediated
autophagy
(CMA)
is
a
selective
form
of
that
contributes
to
the
maintenance
cellular
homeostasis.
CMA
activity
declines
with
age
in
most
tissues
and
systems,
including
immune
system,
due
reduction
levels
lysosome-associated
membrane
protein
type
2A
(LAMP2A),
an
essential
component.
In
this
study,
we
show
overexpressing
copy
hLAMP2A
within
T
cells
since
middle-age
can
prevent
some
their
age-associated
loss
function.
Our
data
support
idea
preserving
LAMP2A
expression
through
genetic
means
leads
enhanced
proliferative
responses,
decreased
number
regulatory
cell
populations,
down-regulated
inhibitory
receptors
by
cells.
During
aging,
elevated
numbers
these
immunosuppressive
populations
significantly
contribute
downregulation
responses.
Using
comparative
proteomics,
confirm
preservation
old
mice
prevents
age-related
changes
both
resting
activated
proteome.
We
also
explore
effect
using
first-in-class
small
molecule
activators
demonstrate
improved
response
upon
administration
mice.
conclude
sustaining
constitutes
potentially
viable
therapeutic
approach
improving
function
age.
Journal of Translational Autoimmunity,
Journal Year:
2025,
Volume and Issue:
10, P. 100269 - 100269
Published: Jan. 8, 2025
Autoimmune
rheumatic
diseases
(ARDs)
are
a
heterogeneous
group
of
conditions
characterized
by
excessive
and
misdirected
immune
responses
against
the
body's
own
musculoskeletal
tissues.
Their
exact
aetiology
remains
unclear,
with
genetic,
demographic,
behavioural
environmental
factors
implicated
in
disease
onset.
One
prominent
hypothesis
for
initial
breach
tolerance
(leading
to
autoimmunity)
is
molecular
mimicry,
which
describes
structural
or
sequence
similarities
between
human
microbial
proteins
(mimotopes).
This
similarity
can
lead
cross-reactive
antibodies
T-cell
receptors,
resulting
an
response
autoantigens.
Both
commensal
microbes
microbiome
pathogens
trigger
thereby
potentially
contributing
onset
ARDs.
In
this
review,
we
focus
on
role
mimicry
rheumatoid
arthritis
systemic
lupus
erythematosus.
Moreover,
implications
also
briefly
discussed
ankylosing
spondylitis,
sclerosis
myositis.
Open Life Sciences,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 1, 2025
Abstract
The
current
study
was
designed
to
explore
the
clinical
significance
of
serum
tissue
inhibitor
metalloproteinase
4
(TIMP4)
levels
in
rheumatoid
arthritis
(RA).
GSE1919
chip
analyzed,
differentially
expressed
genes
(DEGs)
were
identified,
and
gene
ontology
as
well
Kyoto
Encyclopedia
Genes
Genomes
analyses
identified
DEGs
conducted.
Patients
with
RA
(
n
=
96)
healthy
individuals
enrolled
this
study.
Serum
from
participants
collected,
RT-qPCR
WB
have
been
conducted
examine
TIMP4
levels;
additionally,
interleukin
(IL)-6
IL-1β
determined
using
ELISA
method.
Pearson’s
correlation
analysis
for
evaluating
relationships
between
expression
those
IL-6
or
IL-1β.
A
receiver
operating
characteristic
(ROC)
curve
drawn
determine
potential
diagnostic
value
RA.
a
markedly
downregulated
involved
development.
significantly
decreased
patients
RA,
results
ROC
showed
that
may
be
marker.
Furthermore,
concentrations
elevated
Finally,
negative
either
is
reliable
marker
diagnosis.
Immunity & Ageing,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Dec. 15, 2023
Although
the
concept
of
declined
immune
function
associated
with
cancer
has
been
accepted
extensively,
real-world
clinical
studies
focusing
on
analysis
peripheral
blood
changes
underlying
ageing,
immunity
and
are
scarce.In
this
case-control
study,
we
retrospectively
analysed
1375
patients
enrolled
275
age
gender
matched
healthy
individuals.
Flow
cytometry
was
conducted
to
assess
changes.
Further
examined
by
SPSS
17.0
GraphPad
Prism
9
software.Cancer
showed
obviously
decreased
CD3+
T,
CD3+CD4+
Th,
CD3+CD8+
CTL,
CD19+
B,
CD16+CD56+
NK
cell
counts
lower
percentage
PD-1
(programmed
death
protein-1,
PD-1)
positive
cells
than
control
(P
<
0.0001).
For
patients,
reference
range
circulating
PD-1+CD45+
cells,
PD-1+CD3+
T
PD-1+CD3+CD4+
Th
PD-1+CD3+CD8+
CTL
(Cytotoxic
Lymphocyte,
CTL)
were
11.2%
(95%
CI
10.8%-11.6%),
15.5%
14.7%-16.0%),
15.4%
14.9%-16.0%)
14.5%
14.0%-15.5%),
respectively.
Moreover,
reduction
B
accompanied
stage
advancing
0.05).
stage,
but
elevated
in
aged
male
Additionally,
varied
across
types,
raised
stage.
Head
neck,
pancreatic,
gynaecological
lung
demonstrated
a
higher
level
melanoma,
prostate,
breast
0.05).This
study
provides
blood,
confirms
series
accompanying
cancer,
expands
our
real
world
evidence
better
understand
interactions
immunity.
shows
similar
tumor
type
distribution
mutational
burden
(TMB),
supports
that
it
maybe
potential
predictive
biomarker
for
checkpoint
inhibitor
therapy.
Immunity & Ageing,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Nov. 30, 2024
Abstract
Antibodies
are
essential
to
immune
homeostasis
due
their
roles
in
neutralizing
pathogenic
agents.
However,
failures
central
and
peripheral
checkpoints
that
eliminate
autoreactive
B
cells
can
undermine
self-tolerance
generate
autoantibodies
mistakenly
target
self-antigens,
leading
inflammation
autoimmune
diseases.
While
well-studied
some
communicable
diseases,
chronic
conditions,
such
as
obesity
aging,
less
understood.
Obesity
aging
share
similar
aspects
of
dysfunction,
diminished
humoral
responses
heightened
inflammation,
which
disrupt
tolerance
foster
autoantigen
production,
thus
giving
rise
autoantibodies.
In
return,
these
events
may
also
contribute
the
pathophysiology
associated
disorders
linked
development
immunosenescence,
an
age-related
decline
function
heightens
vulnerability
infections,
loss
self-tolerance.
Furthermore,
cumulative
exposure
antigens
cellular
debris
during
perpetuates
pro-inflammatory
pathways,
linking
immunosenescence
with
other
hallmarks,
proteostasis
mitochondrial
dysfunction.
This
review
examines
mechanisms
driving
autoantibody
generation
discusses
key
putative
antigenic
targets
across
conditions.
We
explore
therapeutic
potential
emerging
approaches,
CAR-T/CAAR-T
therapies,
vaccines,
BiTEs,
tackle
autoimmune-related
conditions
obesity.
Seizure,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 1, 2024
Aging
is
a
multifaceted
and
highly
varied
process
in
the
brain.
Identifying
aging
biomarkers
one
means
of
distinguishing
pathological
from
physiological
aging.
The
aim
this
narrative
review
to
focus
on
two
new
developments
field
fluid
draw
attention
excellent
tool
for
early
detection
potential
brain
pathologies
that
delay,
alter,
or
enable
become
pathological.
Pathological
can
lower
threshold
development
specific
diseases
such
as
late-onset
epilepsy.
Fluid
reveal
levels
at
an
stage
thus
indicate
disease
processes
begin
before
symptoms
develop;
they
differ